Compare CBUS & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBUS | WGRX |
|---|---|---|
| Founded | 2010 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.9M | 60.2M |
| IPO Year | 2017 | 2025 |
| Metric | CBUS | WGRX |
|---|---|---|
| Price | $1.57 | $0.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 299.6K | ★ 348.1K |
| Earning Date | 11-13-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,794,000.00 | ★ $34,077,635.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $109.96 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 495.93 |
| 52 Week Low | $1.09 | $0.34 |
| 52 Week High | $3.40 | $7.04 |
| Indicator | CBUS | WGRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 43.63 |
| Support Level | $1.46 | $0.39 |
| Resistance Level | $2.04 | $0.45 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 9.82 | 42.42 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.